Comfort and Vision With TOTAL30 Multifocal Lenses

February 6, 2026 updated by: Scripps Poway Eyecare and Optometry

Evaluation of Wear Comfort and Vision With Total 30 Multifocal Lenses Over 16 Hours of Wear

This study is a single-arm, prospective, observational study conducted at one site to evaluate the comfort and vision of the TOTAL30 Multifocal (T30MF) contact lenses over the course of long wear days. The study will assess the proportion of positive subjective Visual Analog Scale (VAS) assessments of comfort and vision at 10, 12, 14, and 16 hours of wear on Days 1, 7, 14, and 30. Additionally, the study will explore subjective assessments of lens comfort using the CLDEQ-8 survey and measure logMAR visual acuity at both distance and near at Visit 1, Visit 2, and after 1 month of lens wear. Participants will undergo three site visits, with at-home surveys conducted at specified intervals to gather real-time data on comfort and vision.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • San Diego, California, United States, 92131
        • Recruiting
        • Scripps Optometric Group
        • Principal Investigator:
          • Jay Mashouf, OD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adults aged 40 years or older who currently wear soft multi-focal contact lenses.

Description

Inclusion Criteria:

Subjects are eligible for the study if they meet the following criteria:

  • Subjects who currently wear soft multi-focal contact lenses and score <12 on an entering CLDEQ-8 survey.
  • Subjects who are >= 40 years old.
  • Subjects who can and are willing to wear their lenses for 13 hours per day during the study period, and 16 hours per day when questionnaires are being taken.
  • Willing to insert their contact lenses between 6:00 am and 8:00 am on the days when questionnaires will be taken.
  • Vision correctable in soft multi-focal contact lenses to 20/25 (0.10 log MAR) or better in each eye at 6M.
  • Must be able to be successfully fit into the prescription parameters available for Total30 MF contact lenses.
  • Required to have a smartphone and receive push notifications.
  • Willing to attend all study visits.
  • Willing to be diligent about answering the timed surveys in a prompt manner.

Exclusion Criteria:

If any of the following exclusion criteria are applicable, the subject should not be enrolled in the study.

  • Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
  • Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator.
  • Use of isotretinoin-derivatives.
  • Use of lubricating drops.
  • Monocular patients or patients fit with only 1 multifocal lens.
  • Prior refractive surgery.
  • History of herpetic keratitis, ocular surgery, or irregular cornea.
  • Pregnant or lactating.
  • Having participated in a clinical trial in the past 30 days.
  • High-ADD habitual wearers using a different fitting approach than Alcon's multifocal fitting guide (e.g., J&J or CooperVision's fitting guide adopting a modified monovision approach).
  • Are past rigid CL wearers.
  • Have a history of being diagnosed with dry eye or ocular allergies.
  • Have history of severe ocular trauma.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-reported comfort level of the TOTAL30 Multifocal Lens
Time Frame: 16 hours of wear on specified days over a 30-day period
Comfort level assessed using real-time patient-reported data collected at multiple time points throughout the day, with a focus on the end of the wear period. Patients are asked "What is your impression of the COMFORT of these study lenses?" and provide and answer from -50 (Extremely uncomfortable) to +50 (Extremely comfortable) using a sliding digital scale.
16 hours of wear on specified days over a 30-day period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-reported vision quality with the TOTAL30 Multifocal Lens
Time Frame: 16 hours of wear on specified days over a 30-day period
Vision quality assessed using real-time patient-reported data collected at various time points during the day. Patients are asked "What is your impression of the VISION quality of these study lenses?" and provide and answer from -50 (Poor quality) to +50 (Excellent quality) using a sliding digital scale.
16 hours of wear on specified days over a 30-day period

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Contact Lens Dry Eye Questionnaire (CLDEQ-8)
Time Frame: After 1 month of wear
A series of 8 questions that ask participants to rate eye discomfort, eye dryness, and blurry vision on a frequency scale (0 Never, 1 Rarely, 2 Sometimes, 3 Frequently, 4 Constantly) and an intensity scale (0 Never, 1 not intense to 5 Very Intense). Scores on individual questions are added together to determine a total score. Higher values indicate worse outcomes. The minimum score is 1 and the maximum score is 37.
After 1 month of wear
Distance Visual Acuity
Time Frame: After 1 month of wear
After 1 month of wear
Near Visual Acuity
Time Frame: After 1 month of wear
After 1 month of wear

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jay Mashouf, OD, Scripps Optometric Group

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2026

Primary Completion (Estimated)

January 21, 2027

Study Completion (Estimated)

January 21, 2027

Study Registration Dates

First Submitted

November 21, 2025

First Submitted That Met QC Criteria

December 2, 2025

First Posted (Actual)

December 16, 2025

Study Record Updates

Last Update Posted (Actual)

February 9, 2026

Last Update Submitted That Met QC Criteria

February 6, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • JM-25-02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on TOTAL30 Multifocal

Subscribe